bf/NASDAQ:FATE_icon.jpeg

COM:FATETHERAPEUTICS

Fate Therapeutics

  • Stock

USD

Last Close

2.07

22/11 21:00

Market Cap

355.16M

Beta: -

Volume Today

652

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-25.88M
-
-29.99M
15.88%
-33.46M
11.57%
-42.95M
28.36%
-66.60M
55.05%
-98.15M
47.38%
-173.39M
76.66%
-212.15M
22.36%
-281.72M
32.79%
-160.93M
42.88%
depreciation and amortization
496K
-
687K
38.51%
881K
28.24%
971K
10.22%
1.20M
24.00%
2.19M
82.14%
3.09M
40.77%
5.85M
89.50%
13.76M
135.18%
18.28M
32.88%
deferred income tax
3K
-
171K
-
5K
97.08%
-335K
6,800%
-478K
42.69%
1.68M
450.63%
5.07M
202.33%
-7.71M
-
stock based compensation
2.43M
-
2.40M
1.40%
3.18M
32.67%
3.61M
13.25%
6.29M
74.51%
17.41M
176.66%
30.75M
76.64%
54.36M
76.78%
78.73M
44.83%
43.46M
44.80%
change in working capital
17K
-
370K
2,076.47%
1.18M
218.92%
2.08M
76.53%
1.74M
16.27%
3.64M
108.72%
-12.77M
450.91%
2.10M
116.43%
-34.71M
1,754.43%
19.18M
155.26%
accounts receivables
-500K
-
500K
200%
-5.51M
1,203%
-3.16M
42.70%
-29.80M
843.16%
36.65M
222.98%
inventory
-4.25M
-
-4.28M
0.54%
1.55M
136.33%
-5.91M
480.12%
accounts payables
4.25M
-
4.28M
0.54%
-1.55M
136.33%
5.91M
480.12%
14.25M
141.27%
-28.94M
303.06%
other working capital
2.24M
-
3.14M
39.93%
-7.26M
331.15%
5.26M
172.44%
-19.16M
464.36%
11.47M
159.86%
other non cash items
517K
-
8.14M
1,474.08%
-1.61M
119.73%
-613K
61.83%
19.04M
3,206.36%
-7.79M
140.91%
111.42M
1,530.05%
-18.10M
116.24%
-24.27M
34.09%
-44.54M
83.55%
net cash provided by operating activities
-22.42M
-
-18.40M
17.94%
-29.82M
62.11%
-36.91M
23.75%
-38.65M
4.73%
-83.17M
115.20%
-39.23M
52.84%
-162.87M
315.18%
-248.21M
52.40%
-132.26M
46.71%
investments in property plant and equipment
-882K
-
-1.50M
69.84%
-457K
69.49%
-1.73M
277.46%
-2.30M
33.51%
-7.39M
221.10%
-4.93M
33.31%
-50.70M
928.06%
-35.57M
29.86%
-6.15M
82.70%
acquisitions net
150.06M
-
156.14M
4.06%
273.32M
75.04%
-202.32M
174.02%
purchases of investments
-19.68M
-
-39.97M
103.16%
-55.66M
39.25%
-248.86M
347.10%
-277.34M
11.45%
-968.16M
249.08%
-404.80M
58.19%
-358.81M
11.36%
sales maturities of investments
16M
-
31.50M
96.88%
57.50M
82.54%
98.80M
71.83%
121.20M
22.67%
694.84M
473.30%
607.11M
12.63%
477.63M
21.33%
other investing activites
18K
-
-150.06M
-
-156.14M
4.06%
-273.32M
75.04%
202.32M
174.02%
net cash used for investing activites
-882K
-
-1.50M
69.84%
-4.11M
174.63%
-10.20M
147.84%
-463K
95.46%
-157.45M
33,907.13%
-161.08M
2.30%
-324.02M
101.16%
166.75M
151.46%
112.67M
32.44%
debt repayment
-1.75M
-
-1.55M
11.66%
-7.69M
397.35%
-10.76M
39.99%
-15M
-
common stock issued
142K
-
36.73M
25,765.49%
28.85M
21.45%
43.21M
49.77%
134.58M
211.48%
162.41M
20.68%
272.69M
67.91%
411.74M
50.99%
9.21M
97.76%
85K
99.08%
common stock repurchased
-193K
-
2.69M
1,495.34%
2.52M
6.35%
dividends paid
-15.21M
-
-2.52M
-
other financing activites
19.97M
-
420K
97.90%
36.58M
8,608.81%
15.20M
58.46%
3.51M
76.90%
2.52M
28.15%
10.14M
302.26%
41.39M
308.02%
net cash used provided by financing activities
18.37M
-
35.60M
93.85%
57.74M
62.17%
47.44M
17.83%
140.78M
196.73%
149.93M
6.50%
282.84M
88.65%
453.13M
60.21%
9.21M
97.97%
85K
99.08%
effect of forex changes on cash
50K
-
net change in cash
-4.93M
-
15.71M
418.30%
23.80M
51.52%
343K
98.56%
101.67M
29,540.52%
-90.70M
189.21%
82.53M
191.00%
-33.76M
140.91%
-72.25M
113.99%
-19.46M
73.06%
cash at beginning of period
54.04M
-
49.10M
9.13%
64.81M
31.99%
88.73M
36.91%
89.07M
0.39%
190.74M
114.14%
100.04M
47.55%
182.57M
82.50%
148.81M
18.49%
61.33M
58.78%
cash at end of period
49.10M
-
64.81M
31.99%
88.61M
36.72%
89.07M
0.52%
190.74M
114.14%
100.04M
47.55%
182.57M
82.50%
148.81M
18.49%
76.56M
48.55%
41.87M
45.31%
operating cash flow
-22.42M
-
-18.40M
17.94%
-29.82M
62.11%
-36.91M
23.75%
-38.65M
4.73%
-83.17M
115.20%
-39.23M
52.84%
-162.87M
315.18%
-248.21M
52.40%
-132.26M
46.71%
capital expenditure
-882K
-
-1.50M
69.84%
-457K
69.49%
-1.73M
277.46%
-2.30M
33.51%
-7.39M
221.10%
-4.93M
33.31%
-50.70M
928.06%
-35.57M
29.86%
-6.15M
82.70%
free cash flow
-23.30M
-
-19.89M
14.62%
-30.28M
52.20%
-38.63M
27.58%
-40.95M
6.01%
-90.57M
121.16%
-44.16M
51.24%
-213.57M
383.63%
-283.77M
32.87%
-138.42M
51.22%

All numbers in USD (except ratios and percentages)